Literature DB >> 12775504

Diagnostic pathology of microsporidiosis.

Jan M Orenstein1.   

Abstract

Microsporidia are ubiquitous spore-forming parasites that are important worldwide pathogens in the HIV/AIDS pandemic. They are also increasingly being seen in HIV(-) individuals. Infection has been documented in almost every tissue and organ in the body and in a broad spectrum of cell types, including epithelial, mesenchymal, and neural. Microsporidia elicit a wide range of pathology, e.g., inflammation and cell death, and symptoms, e.g., shortness of breath, sinusitis, and diarrhea with wasting. Untreated, microsporidiosis has been documented as a cause of death.

Entities:  

Mesh:

Year:  2003        PMID: 12775504     DOI: 10.1080/01913120309938

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  5 in total

Review 1.  Microsporidiosis: current status.

Authors:  Elizabeth S Didier; Louis M Weiss
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

2.  Induction of host chemotactic response by Encephalitozoon spp.

Authors:  Jeffrey Fischer; Jeffrey West; Nnenaya Agochukwu; Colby Suire; Hollie Hale-Donze
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

Review 3.  Zoonotic potential of the microsporidia.

Authors:  Alexander Mathis; Rainer Weber; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

4.  Toll-like receptor 2 recognition of the microsporidia Encephalitozoon spp. induces nuclear translocation of NF-kappaB and subsequent inflammatory responses.

Authors:  Jeffrey Fischer; Colby Suire; Hollie Hale-Donze
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

5.  Microsporidiosis in South Africa: PCR detection in stool samples of HIV-positive and HIV-negative individuals and school children in Vhembe district, Limpopo Province.

Authors:  A Samie; C L Obi; S Tzipori; L M Weiss; R L Guerrant
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-04-06       Impact factor: 2.184

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.